CrushSCI.com
87.7Average days
73Median days
28Fastest days
187Longest days
532025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

71 days

Design, Synthesis, and Biological Evaluation of 99m Tc‐Labeled Thalidomide Analogs as Novel Tumor‐Targeting Radiopharmaceuticals

Authors
Hassan M. Rashed; Ashraf Mohamed Hamed Mohamed; Ibrahim H. Eissa; Abdallah E. Abdallah; Mohamed Ayman El‐Zahabi; Tamer M. SakrShow moreShow less
Affiliations
1. Labeled Compounds Department, Hot Laboratories and Waste Management Center Egyptian Atomic Energy Authority Cairo Egypt; 2. Radiation Protection Department, Nuclear and Radiological Regulatory Authority Egyptian Atomic Energy Authority Cairo Egypt; 3. Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of Pharmacy (Boys) Al‐Azhar University Cairo Egypt; 4. Radioactive Isotopes and Generator Department, Hot Laboratories and Waste Management Center Egyptian Atomic Energy Authority Cairo EgyptShow moreShow less
Source PDF DOI Publisher page
85 days

Copper‐Mediated Radiofluorination of the Excitatory Amino Acid Transporter 2 (EAAT2)–Targeted PET Tracer [ 18 F]RP‐115: Alternate Synthetic Method

Authors
Sang Hee Lee; Joseph Blecha; Jung Min Kim; Ryan Michael Nillo; Robert R. Flavell; Chih‐Kai Chao; John R. Forsayeth; John M. Gerdes; Henry F. VanBrocklin; David M. WilsonShow moreShow less
Affiliations
1. Department of Radiology and Biomedical Imaging University of California, San Francisco San Francisco California USA; 2. Rio Pharmaceuticals, Inc. San Francisco California USAShow moreShow less
Source PDF DOI Publisher page
118 days

Development of Radioiodinated Tetrahydropyrazolopyridine Inhibitors Targeting mIDH

Authors
Sarandeep Kaur; Sladjana Dukic‐Stefanovic; Lucie Arnaud; Jean‐Michel Chezal; Barbara Wenzel; Rareş‐Petru Moldovan; Klaus Kopka; Aurélie Maisonial‐BessetShow moreShow less
Affiliations
1. Research Site Leipzig, Department of Experimental Neurooncological Radiopharmacy, Institute of Radiopharmaceutical Cancer Research Helmholtz‐Zentrum Dresden‐Rossendorf (HZDR) Leipzig Germany; 2. Faculty of Chemistry and Food Chemistry, School of Science Technische Universität Dresden Germany; 3. Inserm, Imagerie Moléculaire et Stratégies Théranostiques, UMR 1240 Université Clermont Auvergne Clermont‐Ferrand France; 4. German Cancer Consortium (DKTK) Partner Site Dresden and German Cancer Research Center (DKFZ) Heidelberg Germany; 5. National Center for Tumor Diseases (NCT), NCT/UCC Dresden, a Partnership Between DKFZ Faculty of Medicine and University Hospital Carl Gustav Carus TUD Dresden University of Technology, and Helmholtz‐Zentrum Dresden‐Rossendorf (HZDR) Dresden GermanyShow moreShow less
Source PDF DOI Publisher page
68 days

Synthesis of USP Grade [2,3,7‐ 13 C 3 ]‐Nicotinamide for Human Pharmacokinetic Studies

Authors
Bruce G. Szczepankiewicz; Karsten J. Koppetsch; Michael P. Drolet; David Cao; Jonathan N. Kremsky; Eric E. Buck; George Rotsides; Greg Griffin; Siead Zegar; Alan Henderson; David J. LivingstonShow moreShow less
Affiliations
1. Metro International Biotech LLC Worcester Massachusetts USA; 2. Esteve CDMO Morton Grove Illinois USAShow moreShow less
Source PDF DOI Publisher page
69 days

Synthesis of a C‐14 Labeled Heme

Authors
Cecilia Ericsson; Jonas Bergare; Charles S. ElmoreShow moreShow less
Affiliations
1. Early Chemical Development, Pharmaceutical Sciences, R&D AstraZeneca Göteborg Sweden; 2. Early Chemical Development, Pharmaceutical Sciences, R&D AstraZeneca Boston Massachusetts USAShow moreShow less
Source PDF DOI Publisher page
46 days

Simple and Efficient Automated Radiosynthesis of 1‐[ 18 F]‐IPA Using Solid‐Phase Extraction Cartridges Purification

Authors
Weixuan Dong; Cong Shen; Ruxi Chang; Zhewei Zhang; Chen Niu; Xiaoyi DuanShow moreShow less
Affiliations
1. PET/CT the First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi Province ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS take to review a manuscript?

As of 2026-11-18, CrushSCI has 20 complete review records for JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. The fastest paper went from submission to acceptance in 28 days (Fully Automated Production of Multiple 11 C‐Labeled PET Tracers Using a Self‐Cleaning TracerMaker Radiosynthesizer, received 2026-03-25, accepted 2026-04-22); the slowest took 187 days. The average is 87.7 days and the median is 73 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.